Press releases
Browse US-specific press releases here.
Please visit our Global website for access to global press releases dating back to 2009.
-
GSK ships 2018-19 seasonal influenza vaccines for US market
GSK will begin shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2018-19 flu season.
-
Positive results from Harmony Outcomes study of albiglutide published in The Lancet (1)
GSK and the Duke Clinical Research Institute (DCRI) today announced publication of positive results from the Harmony Outcomes study.
-
ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV
Priority review voucher used with NDA submission with anticipated target action date of six months.
-
GSK presents new efficacy and safety data of an anti GM-CSF antibody in patients with rheumatoid arthritis
Marked patient benefit observed in phase II study supports further clinical development of GSK3196165 for RA.
-
GSK delivers Q3 sales of £8.1 billion, +3% AER, +6% CER
Total EPS 28.8p, +16% AER, +23% CER; Adjusted EPS 35.5p, +10% AER, + 14% CER
-
Once-daily Trelegy Ellipta gains expanded COPD indication in Europe
First single inhaler triple therapy to be specifically indicated for COPD patients not adequately treated with dual bronchodilation.
-
GSK awards Triangle nonprofits making a dynamic IMPACT on health outcomes
Ten nonprofits will receive $40,000 to support life coaching, mentorship, healthy eating, literacy, and other social determinants of health.
-
GSK Announces Winners of 2016 Discovery Fast Track Boston Challenge
GSK has named two academic researchers winners of the 2016 Discovery Fast Track Boston Challenge.
-
GSK Consumer Healthcare Launches FLONASE® Sensimist™ Allergy Relief Nationwide
New OTC product with unique technology aims to help allergy sufferers find more complete relief.
-
‘Get HYPE Philly!’ thrilled to win a Healthy10 Award
GSK IMPACT Grant winners recognized for building healthier schools and workforce for young people in Philadelphia.
-
Science is a Slam Dunk with GSK Science in the Summer™
Classes return to local libraries again this summer with new Science of Sports course; online registration begins in May 2017
-
Local nonprofits making the Triangle healthier can win $40,000
GlaxoSmithKline and Triangle Community Foundation today issued the call for applications for the 2017 GSK IMPACT Awards.
-
Local nonprofits making Philly healthier can win $40,000
GlaxoSmithKline and The Philadelphia Foundation today issued the call for applications for the 2017 GSK IMPACT Awards.
-
GSK announces US regulatory submission seeking expanded indication for Fluarix® Quadrivalent (Influenza Vaccine) for infants 6 months and older
GSK today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA).
-
Derek Hough Sends Social Media Stars, the Eh Bee Family, on Cross-Country Road Trip to Reimagine What’s Possible Despite Allergies
The Eh Bees will tackle allergy-triggering jobs to support local communities in seven cities.
-
GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD
GSK today announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD.
-
GSK demonstrates leadership in respiratory medicine at ATS 2017 with over 50 abstracts from across comprehensive portfolio
GSK will present 59 abstracts at the American Thoracic Society (ATS) conference 19-24 May, Washington DC, US.
-
GSK presents college scholarships to Triangle Region, NC students who have overcome adversity to pursue their dreams (1)
Media representatives are invited to GSK to attend a special event honoring the 2017 winners of the GSK Opportunity Scholarship program.
-
GSK presents college scholarships to Philadelphia students who have overcome adversity to pursue their dreams (1)
Media representatives are invited to GSK to attend a special event honoring the 2017 winners of the GSK Opportunity Scholarship program.
-
GSK ships 2017-18 seasonal influenza vaccines for US market
GSK has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and lot-release approval from the US FDA.
